Clinical Trials Browser

Has results × Leiomyosarcoma × Gemcitabine × Clear all

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Phase 2 Completed

54 enrolled 12 charts

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT02303262 2019-01-29

SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

Phase 2 Completed

20 enrolled 11 charts

Leiomyosarcoma

NCT00887809 2016-01-25

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Phase 2 Completed

47 enrolled 7 charts

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma

NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Phase 2 Completed

47 enrolled 16 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms